Need Access?
If you are a licensed provider and would like to access the Practitioner List, or your payment statements please e-mail nlpdp@bell.ca to request a USERNAME and PASSWORD.

 
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
NLPDP Benefit Status Effective February 1, 2021222021-Jan-25Word PDF
NIDPF Vol. 83 Supplement Effective February 1, 2021 - Refer to Bulletin #22 for Benefit Status212021-Jan-25Word PDF
Benefit List Update_Criteria Update_Afinitor, Nexavar, Sutent, and Votrient202021-Jan-22Word PDF
Benefit list update_New additions to an existing category_ EMERADE 0.3mg & 0.5mg 192021-Jan-20Word PDF
Benefit list updates_New additions_Special Authorization_Movapo 30mg 3ml Pen182021-Jan-20Word PDF
Benefit Status Update: Reviewed but not recommended for coverage172021-Jan-20Word PDF
NLPDP Benefit Status Effective February 1, 2021162021-Jan-20Word PDF
Update: Short-Stock: Brimonidine Tartrate . 0.2 percent152021-Jan-19Word PDF
Update: Short-Stock: Famciclovir 250mg142021-Jan-19Word PDF
Update: Short-Stock: Irbesartan 150mg 132021-Jan-19Word PDF
Benefit List Updates_New Addition_Cabometyx 20mg, 40mg, 60mg122021-Jan-18Word PDF
Follow-up to Bulletin No. 175, dated November 30, 2020.112021-Jan-12Word PDF
Short-Stock: Atropine 1 Percent102021-Jan-12Word PDF
SiteSmart Pen Needles 32G 4 MM92021-Jan-12Word PDF
NIDPF Delisting82021-Jan-12Word PDF
Short-Stock: Estradiol Transdermal 75 ug Patch 72021-Jan-12Word PDF
Short-Stock: Dextroamphetamine Extended Release 15mg62021-Jan-12Word PDF
Short Stock - Verapamil SR 120 mg52021-Jan-11Word PDF
Update: Short-Stock - Irbesartan 300 mg42021-Jan-08Word PDF
Short-Stock: Oxcarbazepine 300mg32021-Jan-05Word PDF
Page  Go
Page 1 of 53
Document Name: Date Range: To


Document NameDateView
Coverage Status Table - January 20212021-Jan-21 PDF
Coverage Status Table - December 20202020-Dec-10 PDF
Coverage Status Table - November 20202020-Nov-19 PDF
Coverage Status Table - October 20202020-Oct-16 PDF
Coverage Status Table - September 20202020-Sep-22 PDF
Coverage Status Table - August 20202020-Aug-24 PDF
Coverage Status Table - July 20202020-Jul-22 PDF
Coverage Status Table - June 20202020-Jun-25 PDF
Coverage Status Table - May 20202020-May-22 PDF
Coverage Status Table - April 20202020-Apr-24 PDF
Coverage Status Table - March 20202020-Apr-02 PDF
Coverage Status Table - February 20202020-Feb-14 PDF
Coverage Status Table - January 20202020-Jan-09 PDF
Coverage Status Table - December 20192019-Dec-20 PDF
Coverage Status Table - November 20192019-Nov-22 PDF
Coverage Status Table - October 20192019-Oct-25 PDF
Coverage Status Table - September 20192019-Sep-24 PDF
Coverage Status Table - August 20192019-Aug-27 PDF
Coverage Status Table - July, 20192019-Jul-05 PDF
Coverage Status Table - June 20192019-Jun-18 PDF
Page  Go
Page 1 of 2
Document Name: Date Range: To


Document NameDateView
Diabetic Listing - January 12, 2021 (Refer to Bulletin #9 posted on January 12, 2021)2021-Jan-12Word PDF
Diabetic Listing - May, 2020(Refer to Bulletin #77 posted on May 1, 2020)2020-May-04Word PDF
Diabetic Listing - October, 2019 (Refer to Bulletin #206 posted on October 29, 2019)2019-Oct-30Word PDF
Diabetic Listing - July, 2019 (Refer to Bulletin #132 posted on July 12, 2019)2019-Jul-12Word PDF
Diabetic Listing - March, 2019 (Refer to Bulletin #56 posted on March 22, 2019)2019-Mar-22Word PDF
 
Page 1 of 1
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Benefit List Update_Criteria Update_Afinitor, Nexavar, Sutent, and Votrient202021-Jan-22Word PDF
Benefit list update_New additions to an existing category_ EMERADE 0.3mg & 0.5mg 192021-Jan-20Word PDF
Benefit list updates_New additions_Special Authorization_Movapo 30mg 3ml Pen182021-Jan-20Word PDF
Benefit List Updates_New Addition_Cabometyx 20mg, 40mg, 60mg122021-Jan-18Word PDF
Benefit List Update_New Addition_Open Benefit: Xaltral and Generics1872020-Dec-31Word PDF
Benefit List Update: New Addition_ Special Authorization_MAVENCLAD 10mg tablets1842020-Dec-22Word PDF
Benefit List Update: New additions to an existing category: Nucala 1812020-Dec-21Word PDF
Benefit List Update: New Addition_ DOVATO 50 MG-300 MG TABLET1802020-Dec-17Word PDF
Benefit List Update_Criteria Update_Prevacid and Generics1792020-Dec-07Word PDF
Benefit List Update_Criteria Update_Actos1782020-Dec-04Word PDF
Benefit List Update: New Addition: Cresemba1692020-Nov-13Word PDF
Benefit List Update: New Addition: Mezera Rectal Foam 1682020-Nov-12Word PDF
Revised Criteria Update: Maviret1672020-Nov-09Word PDF
Benefit List Update_Criteria Update_Vyvanse1662020-Nov-04Word PDF
Delisting - Neupro 1mg, 3mg 1642020-Oct-27Word PDF
New Addition to an existing category: Rituximab Biosimilar: RIXIMYO1602020-Oct-19Word PDF
Removal from market: Fibristal 5mg1552020-Oct-06Word PDF
Benefit List Update: New Addition_Open Benefit: Mycophenolate Mofetil1522020-Sep-30Word PDF
New addition to an existing category: Special Authorization: Fragmin Syringe1512020-Sep-25Word PDF
Reviewed and Rejected: Foquest Capsules1502020-Sep-25Word PDF
Page  Go
Page 1 of 5
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
Update: Short-Stock: Brimonidine Tartrate . 0.2 percent152021-Jan-19Word PDF
Update: Short-Stock: Famciclovir 250mg142021-Jan-19Word PDF
Update: Short-Stock: Irbesartan 150mg 132021-Jan-19Word PDF
Short-Stock: Atropine 1 Percent102021-Jan-12Word PDF
Short-Stock: Estradiol Transdermal 75 ug Patch 72021-Jan-12Word PDF
Short-Stock: Dextroamphetamine Extended Release 15mg62021-Jan-12Word PDF
Short Stock - Verapamil SR 120 mg52021-Jan-11Word PDF
Update: Short-Stock - Irbesartan 300 mg42021-Jan-08Word PDF
Short-Stock: Oxcarbazepine 300mg32021-Jan-05Word PDF
Short-Stock: Oxcarbazepine 150mg & 600mg22021-Jan-04Word PDF
Short-Stock: Brimonidine Tartrate . 0.2 Percent12021-Jan-04Word PDF
Update: Short-Stock: Famciclovir 125mg and 500mg1902020-Dec-31Word PDF
Short-Stocks: Famciclovir 125mg, 250mg, 500mg1772020-Dec-03Word PDF
Update: Short-Stock: Dipyridamole / Acetylsalicylic Acid 200mg / 25mg1712020-Nov-19Word PDF
Short-Stock - Irbesartan 300 mg1612020-Oct-23Word PDF
Short-Stock: Eletriptan Hydrobromide 40mg 1572020-Oct-13Word PDF
Short-Stock - Famciclovir 500mg1542020-Oct-01Word PDF
Update: Short-Stock - Anagrelide Hydrochloride 0.5 mg1482020-Sep-25Word PDF
Short-Stock- Irbesartan 150mg1472020-Sep-24Word PDF
Update: Short-Stock - Carbamazepine 100mg/5ml1432020-Sep-22Word PDF
Page  Go
Page 1 of 10
Document Name: Bulletin #: Date Range: To


Document NameBulletin NumberDateView
NLPDP Benefit Status Effective February 1, 2021222021-Jan-25Word PDF
NIDPF Vol. 83 Supplement Effective February 1, 2021 - Refer to Bulletin #22 for Benefit Status212021-Jan-25Word PDF
NIDPF Delisting82021-Jan-12Word PDF
Online version of NIDPF Vol. 83 effective January 1, 20211892020-Dec-31Word PDF
NLPDP Benefit Status Effective January 1, 20211832020-Dec-21Word PDF
NIDPF Vol. 83 Supplement Effective January 1, 2021 - Refer to Bulletin #183 for Benefit Status1822020-Dec-21Word PDF
Online version of NIDPF Vol. 83 effective December 1, 20201762020-Dec-01Word PDF
delisting - pms-Progesterone 100mg Capsules1742020-Nov-19Word PDF
NLPDP Benefit Status Effective December 1, 20201732020-Nov-19Word PDF
NIDPF Vol. 83 Supplement Effective December 1, 2020 - Refer to Bulletin #173 for Benefit Status1722020-Nov-19Word PDF
Benefit list update: Special Authorization MICRONIZED PROGESTERONE 100mg capsules1702020-Nov-19Word PDF
Online version of NIDPF Vol. 83 effective November 1, 20201652020-Oct-30Word PDF
NLPDP Benefit Status Effective November 1, 20201632020-Oct-27Word PDF
NIDPF Vol. 83 Supplement Effective November 1, 2020 - Refer to Bulletin #163 for Benefit Status1622020-Oct-26Word PDF
Delisting - pms-Repaglinide1582020-Oct-14Word PDF
Online version of NIDPF Vol. 83 effective October 1, 20201532020-Oct-01Word PDF
NLPDP Benefit Status Effective October 1, 20201452020-Sep-22Word PDF
NIDPF Vol. 83 Supplement Effective October 1, 2020 - Refer to Bulletin #145 for Benefit Status1442020-Sep-22Word PDF
Delisting from NIDPF and NLPDP Benefit List Effective October 1, 20201372020-Sep-14Word PDF
Online version of NIDPF Vol. 82 effective September 1, 20201252020-Sep-02Word PDF
Page  Go
Page 1 of 5
Document Name: Date Range: To


Document NameDateView
2021 - Payment Schedule2020-Dec-17Word PDF
2020 Payment Schedule2019-Dec-09Word PDF
 
Page 1 of 1